BST1 and acute lymphoblastic leukemia: Further evidence derives from the study by Mirkowska et al.46 of the B-cell precursor acute lymphoblastic leukemia (BCP-ALL) surface proteome in which CD157 was identified as one of a restricted set of markers with significantly higher expression in BCP-ALL cells with respect to normal bone marrow B cell populations.